Not only does the AMTA expand patients’ options, it helps ensure patients’ safety. In addition, it returns the decision-making authority to the patient, and reinforces the sanctity of the doctor-patient relationship.

We're proud to announce that Access to Medical Treatment Act was recently introduced in the House by Representatives Burton and DeFazio (H.R. 2792) and we expect the Senate to reintroduce it shortly. There have been changes to the bill to make it stronger. Language (taken from reimportation bills) names the countries that the medical treatment may come from (Section 3.4) and are as follows: a member country of the European Union or the European Free Trade Association, Canada, Australia, New Zealand, or Japan.

We will have to prepare for significant opposition from organizations such as the American Medical Association, the American Heart Association, the Center for Science in the Public Interest, Federation of State Medical Boards, and others. To counteract that opposition and to help build awareness of this crucial bill, we will be contacting other organizations to endorse the bill as well as healthcare practitioners. We have created a strong AMTA presence on our website (visit www.healthfreedom.net/AMTA/default.asp and have developed a cohesive strategy to raise awareness of AMTA and to encourage Congressional support.

But we can't do it alone. Please visit our website, read about the bill and take action. Contact your representatives. Tell your friends about the bill. If you’re an organization or healthcare professional contact AAHF (office@healthfreedom.net) and let us know that you endorse AMTA. Additionally, if you are aware of therapies that may be covered by this bill, please let us know.

Brenna Hill
Executive Director
American Association for Health Freedom
PO Box 458
Great Falls, VA 22066
703 759-0662
www.healthfreedom.net

Send a letter to the following decision maker(s):

Your Congressperson

Below is the sample letter:

Subject: Support H.R. 2792, AMTA

Dear [decision maker name automatically inserted here],

Every year, Americans with severe chronic or terminal diseases and their doctors face an FDA Catch-22. Access to Medical Treatment Act (AMTA), HR 2792 would help fix this dilemma. I am writing to ask for your support and sponsorship this crucial bill.

This is truly a patients' Bill of Rights. It returns the decision-making authority to the patient, and reasserts the sanctity of the doctor-patient relationship. Most importantly, it gives American consumers access to the many drugs and therapies that are available to people all over the world, but which cannot be sold in the United States.

Today, we have a two-tiered medical system: one track for people who can afford to fly to Germany or Italy or Canada for life-enhancing and life-saving treatments; and one track for the rest of us. As a result, we are literally encouraging a black market in such things as cancer and arthritis treatments. We are also condemning millions of Americans to a life of pain and even premature death because th means only the wealthy can afford the best healthcare.